Design and Profiling of GS-9148, a Novel Nucleotide Analog Active against Nucleoside-Resistant Variants of Human Immunodeficiency Virus Type 1, and Its Orally Bioavailable Phosphonoamidate Prodrug, GS-9131CIHIAR, Tomas; RAY, Adrian S; WHITE, Kirsten L et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 2, pp 655-665, issn 0066-4804, 11 p.Article

In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4MARGOT, Nicolas A; HLUHANICH, Rebecca M; JONES, Gregg S et al.Antiviral research. 2012, Vol 93, Num 2, pp 288-296, issn 0166-3542, 9 p.Article

Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovirMARCHAND, Bruno; WHITE, Kirsten L; LY, John K et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 8, pp 2911-2919, issn 0066-4804, 9 p.Article

The HIV-1 Reverse Transcriptase MI841 Mutation Enhances the E138K-Associated Resistance to Rilpivirine and Decreases Viral FitnessKULKARNI, Rima; BABAOGLU, Kerim; LANSDON, Eric B et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 1, pp 47-54, issn 1525-4135, 8 p.Article

The balance between NRTI discrimination and excision drives the susceptibility of HIV-1 RT mutants K65R, M184V and K65R+M184VLY, John K; MARGOT, Nicolas A; MACARTHUR, Holly L et al.Antiviral chemistry & chemotherapy. 2007, Vol 18, Num 6, pp 307-316, issn 0956-3202, 10 p.Article

The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutationsWHITE, Kirsten L; CHEN, James M; FENG, Joy Y et al.Antiviral therapy (London). 2006, Vol 11, Num 2, pp 155-163, issn 1359-6535, 9 p.Article

Inhibition of 2',5'-Oligoadenylate Synthetase Expression and Function by the Human Cytomegalovirus ORF94 Gene ProductTAN, Joanne C. G; AVDIC, Selmir; CAO, John Z et al.Journal of virology. 2011, Vol 85, Num 11, pp 5696-5700, issn 0022-538X, 5 p.Article

Mechanism of Resistance to GS-9148 Conferred by the Q151L Mutation in HIV-1 Reverse TranscriptaseSCARTH, Brian J; WHITE, Kirsten L; CHEN, James M et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 6, pp 2662-2669, issn 0066-4804, 8 p.Article

Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patientsWATERS, Joshua M; O'NEAL, Wesley; WHITE, Kirsten L et al.Antiviral therapy (London). 2009, Vol 14, Num 2, pp 231-239, issn 1359-6535, 9 p.Article

Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutationsWHITE, Kirsten L; CHEN, James M; MARGOT, Nicolas A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 3, pp 992-1003, issn 0066-4804, 12 p.Article